The "Respiratory Infection Diagnostic Markets by Technology, PLEX, Place and by Region with COVID-19 Impact & Forecasting/Analysis, and Executive and Consultant Guides 2020-2024" report has been added to ResearchAndMarkets.com's offering.

COVID-19 has broken open the market for point of care testing of respiratory infections. Now the competition for market share begins in earnest. Large new markets are opening up. In health facilities, clinics, physicians' offices and elsewhere. And let's not forget the screening market, not just for COVID, but for the rest of the 20 something respiratory pathogens as well. Multiplex vs single plex?

Explore the rapidly changing market as competitors jockey for position in new markets that are not yet well understood.

New technology is forever changing the diagnosis of respiratory infections. Shrinking time to result is opening up markets multiple times the size of current microbiology based practice. Diagnosis has already moved into the Emergency Room. It is now moving to the Physician's Office Lab. Could the Home be next?

The Multiplex factor is creating market confusion while lowering costs and improving care but important factors are holding back progress. The widespread nature of respiratory infections, (young people can get 8 colds a year) means that potential market sizes are enormous. Respiratory, already the largest infectious disease category could multiply in size. This is a growth opportunity for all diagnostic companies. Understand the opportunity and the risk with this in-depth report.

Key Topics Covered

i. Respiratory Infections Diagnostic Market - Strategic Situation Analysis and Impact of COVID-19

ii. Guide for Executives, Marketing, Sales and Business Development Staff

iii. Guide for Management Consultants and Investment Advisors

1. Introduction and Market Definition

1.1 What are Respiratory Infections?

1.2 The Role of Diagnosis & Treatment

1.3 Market Definition

1.3.1 Revenue Market Size

1.4 Methodology

1.4.1 Authors

1.4.2 Sources

1.5 A Spending Perspective on Clinical Laboratory Testing

1.5.1 An Historical Look at Clinical Testing

2. Market Overview

2.1 Players in a Dynamic Market

2.1.1 Academic Research Lab

2.1.2 Diagnostic Test Developer

2.1.3 Instrumentation Supplier

2.1.4 Distributor and Reagent Supplier

2.1.5 Independent Testing Lab

2.1.6 Public National/regional lab

2.1.7 Hospital lab

2.1.8 Physician Office Labs

2.1.9 Audit Body

2.1.10 Certification Body

2.2 Respiratory Infections

2.2.1 Upper vs. Lower - Marketing Implications

2.2.2 Understanding the Role of Pneumonia

2.2.3 Bacterial Infections

2.2.3.1 Streptococcal Infections

2.2.3.2 Acute Otitis Media

2.2.3.3 Bacterial Rhinosinusitis

2.2.3.4 Diphtheria

2.2.3.5 Pneumococcal Pneumonia

2.2.3.6 Haemophilus Pneumonia

2.2.3.7 Mycoplasma Pneumonia (Walking Pneumonia)

2.2.3.8 Chlamydial Pneumonias and Psittacosis

2.2.3.9 Health Care-Associated Pneumonia

2.2.3.10 Pseudomonas Pneumonia

2.2.3.11 Pertussis (Whooping Cough)

2.2.3.12 Legionnaires Disease

2.2.4 Tuberculosis - A Special Case

2.2.5 Viral Infections

2.2.5.1 The Common Cold

2.2.5.2 Influenza

2.2.5.3 Viral Pneumonia

2.2.5.4 SARS and MERS

2.2.5.5 Measles (Rubeola)

2.2.5.6 Rubella (German Measles)

2.2.5.7 Chickenpox and Shingles

2.2.6 Fungal and Other Pathogens

2.2.6.1 Histoplasmosis

2.2.6.2 Coccidioidomycosis.

2.2.6.3 Blastomycosis

2.2.6.4 Mucormycosis

2.2.6.5 Aspergillosis

2.2.6.6 Pneumocystis Pneumonia

2.2.6.7 Cryptococcosis

2.3 Diagnostics - A Changing Role

2.3.1 Historical Practice

2.3.2 Current Diagnostics

2.3.3 The Multiplex Vector

2.3.4 Future Diagnostics - The Question of When and Where

2.3.5 Respiratory Infection Diagnostics - The Destination

2.3.6 Diagnostics as Defensive Weapons

3. Market Trends

3.1 Factors Driving Growth

3.1.1. Syndromic Multiplexing

3.1.2 T.A.T

3.1.3 Antimicrobial Resistance Movement

3.1.4 Pandemic Mitigation

3.1.5 An Aging at Risk Population

3.2 Factors Limiting Growth

3.2.1 The Cost Curve

3.2.2 Regulation and coverage

3.2.3 Laissez Faire

3.3 Instrumentation and Automation

3.3.1 The Shrinking Multiplexing Machine

3.3.2 Bioinformatics Networking and Anonymous Reporting

3.4 Diagnostic Technology Development

3.4.1 The Key Role of Time to Result

3.4.2 Single Cell Genomics Changes the Picture

3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment

3.4.4 Pathogen Identification - A Projected Timetable of the Future

Story continues

4. Respiratory Infection Diagnostics Recent Developments

4.1 Recent Developments - Importance and How to Use This Section

4.1.1 Importance of These Developments

4.1.2 How to Use This Section

5. Profiles of Key Players

6. The Global Market for Respiratory Infection Diagnostics

6.1 Global Market Overview by Country

6.1.1 Table - Global Market by Country

6.1.2 Chart - Global Market by Country

See more here:
Global Respiratory Infection Diagnostic Markets by Technology, PLEX, Place and Region - COVID-19 Impact & Forecasting/Analysis with Executive...